XDC

WuXi XDC is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) dedicated to the antibody-drug conjugate (ADC) and broader bioconjugate market. Formed as a joint venture between WuXi Biologics and WuXi AppTec, the company provides a comprehensive, single-source platform that spans from discovery and development to commercial-scale manufacturing. Their integrated "one-stop" approach significantly accelerates development timelines by co-locating the production of antibodies, linkers, payloads, and the final conjugated product. WuXi XDC supports a diverse range of modalities beyond ADCs, including peptide-drug conjugates (PDCs) and radionuclide-drug conjugates (RDCs), serving a global client base in the biopharmaceutical sector.